CCR2 and neoplasm: In irradiated MC38 and LLC tumor models, IFN-β can induce mCCL12 expression by activating the stimulator of interferon genes (STING) pathway, which in turn mobilizes CCR2+ Mo-MDSCs into tumors, leading to radioresistance (105).